Abstract

Activation of β(2)-adrenegic receptor (β(2)-AR) leads to an increase in intracellular cAMP and activation of ERK. These two signals are activated by the interaction of the receptor with different transducer partners. We showed that the intrinsic activities of β(2)-AR ligands for stimulating cAMP production and ERK phosphorylation responses in HEK-293 cells were not correlated. The lack of correlation resulted mainly from the discrepancy between the intrinsic activities of two groups of ligands for these two responses: The first group consisted of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP production but displayed very weak effect on ERK phosphorylation. The second group comprised adrenaline and noradrenaline which displayed higher intrinsic activity for the ERK phosphorylation than for the cAMP response. Thus, both groups behaved as functionally selective ligands. The functional selectivity of the first group was observable only in adherent cells when confluence was approximately 100%. When cell-cell contact was minimized either by decreasing the density of the adherent cells or by bringing the cells into suspension, the first group of ligands gained the ability to stimulate ERK phosphorylation without a change in their effect on cAMP production. In contrast, selectivity of the second group was independent of the adherence state of the cells. Our results show that the inherent "bias" of ligands in coupling a G protein-coupled receptor to different transducers may not always be revealed as functional selectivity when there is a "cross-talk" between the signaling pathways activated by the same receptor.

Highlights

  • Activation of ␤2-adrenegic receptor (␤2-AR) leads to an increase in intracellular cAMP and activation of extracellular signal-regulated kinase (ERK)

  • We showed that the intrinsic activities of ␤2-AR ligands for stimulating cAMP production and ERK phosphorylation responses in HEK-293 cells were not correlated

  • The lack of correlation resulted mainly from the discrepancy between the intrinsic activities of two groups of ligands for these two responses: The first group consisted of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP production but displayed very weak effect on ERK phosphorylation

Read more

Summary

EXPERIMENTAL PROCEDURES

Cell culture media and fetal bovine serum (FBS) were purchased from Biological Industries (Kibbutz Beit-Haemek, Israel). Receptor ligands were from either Tocris (Ellisville, MO) or Sigma. Dibutyryl-cAMP (db-cAMP), isobutylmethylxanthine, MTT, myristoylated protein kinase A inhibitor peptide (myr-PKI) and pertussis toxin (PTX) were from Sigma. Complete Mini protease inhibitors were from Roche Diagnostics. Primary and HRP-conjugated secondary antibodies, enhanced chemiluminescence substrate, siRNAs targeting the. ␣ and ␤ catalytic subunits of PKA (sc-36240 and sc-39158, respectively), and control siRNA (sc-37007) were from Santa Cruz Biotechnology (Santa Cruz, CA).

Cell Culture
ERK Phosphorylation Assay
Determination of cAMP Accumulation in Intact Cells
RESULTS
Characterization of ERK Phosphorylation Responses
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.